Cargando…
Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481089/ https://www.ncbi.nlm.nih.gov/pubmed/34686374 http://dx.doi.org/10.1016/j.annder.2021.07.008 |
| _version_ | 1784576606144036864 |
|---|---|
| author | Agharbi, F.-Z. Eljazouly, M. Basri, G. Faik, M. Benkirane, A. Albouzidi, A. Chiheb, S. |
| author_facet | Agharbi, F.-Z. Eljazouly, M. Basri, G. Faik, M. Benkirane, A. Albouzidi, A. Chiheb, S. |
| author_sort | Agharbi, F.-Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8481089 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84810892021-09-30 Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine Agharbi, F.-Z. Eljazouly, M. Basri, G. Faik, M. Benkirane, A. Albouzidi, A. Chiheb, S. Ann Dermatol Venereol Letter to the Editor Elsevier Masson SAS. 2022-03 2021-09-30 /pmc/articles/PMC8481089/ /pubmed/34686374 http://dx.doi.org/10.1016/j.annder.2021.07.008 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Agharbi, F.-Z. Eljazouly, M. Basri, G. Faik, M. Benkirane, A. Albouzidi, A. Chiheb, S. Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine |
| title | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine |
| title_full | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine |
| title_fullStr | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine |
| title_full_unstemmed | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine |
| title_short | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine |
| title_sort | bullous pemphigoid induced by the astrazeneca covid-19 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481089/ https://www.ncbi.nlm.nih.gov/pubmed/34686374 http://dx.doi.org/10.1016/j.annder.2021.07.008 |
| work_keys_str_mv | AT agharbifz bullouspemphigoidinducedbytheastrazenecacovid19vaccine AT eljazoulym bullouspemphigoidinducedbytheastrazenecacovid19vaccine AT basrig bullouspemphigoidinducedbytheastrazenecacovid19vaccine AT faikm bullouspemphigoidinducedbytheastrazenecacovid19vaccine AT benkiranea bullouspemphigoidinducedbytheastrazenecacovid19vaccine AT albouzidia bullouspemphigoidinducedbytheastrazenecacovid19vaccine AT chihebs bullouspemphigoidinducedbytheastrazenecacovid19vaccine |